A new Government Accountability Office report highlights a critical gap in the Controlled Substances Act, revealing that key terms like "potential for abuse" and "accepted medical use" remain undefined by federal law. This ambiguity could influence how substances are classified and regulated under current drug policies. The report suggests the lack of clear definitions may lead to inconsistencies in enforcement and scheduling decisions. Experts and policymakers are likely to scrutinize whether these vague standards need formal clarification to ensure fair and transparent drug control measures.
A GAO report notes that the Controlled Substances Act does not define "potential for abuse" or "accepted medical use."
